Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Data Collection and Prospective Treatment Study to Evaluate the Efficacy of ProgenaMatrix™ in the Management of Diabetic Foot Ulcers

NCT06292026 is registered in ClinicalTrials.gov with ProgenaCare Global, LLC as lead sponsor.

NCT NCT06292026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06292026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Data Collection and Prospective Treatment Study to Evaluate the Efficacy of ProgenaMatrix™ in the Management of Diabetic Foot Ulcers
Lead sponsor
ProgenaCare Global, LLC
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 14, 2022
Completion date
September 30, 2026
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic foot ulcer